INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 146 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,776,030 | +79.2% | 95,794 | +6.9% | 0.00% | +50.0% |
| Q2 2023 | $991,016 | -61.3% | 89,603 | -53.1% | 0.00% | -50.0% |
| Q1 2023 | $2,563,718 | +17.3% | 190,895 | +8.1% | 0.00% | 0.0% |
| Q4 2022 | $2,185,282 | +33.6% | 176,660 | +50.6% | 0.00% | +33.3% |
| Q3 2022 | $1,636,000 | +10.9% | 117,338 | +9.8% | 0.00% | +50.0% |
| Q2 2022 | $1,475,000 | -9.1% | 106,868 | +7.0% | 0.00% | 0.0% |
| Q1 2022 | $1,623,000 | +12.9% | 99,849 | +13.1% | 0.00% | 0.0% |
| Q4 2021 | $1,437,000 | – | 88,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
| Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
| DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
| GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
| BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
| Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
| ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
| Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
| QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
| Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |